Related references
Note: Only part of the references are listed.Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence
Matthieu Camus et al.
CANCER RESEARCH (2009)
Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
Theocharis Panaretakis et al.
EMBO JOURNAL (2009)
Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
David Sancho et al.
NATURE (2009)
Discovery and validation of protein abundance differences between follicular thyroid neoplasms
Romana T. Netea-Maier et al.
CANCER RESEARCH (2008)
The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death
T. Panaretakis et al.
CELL DEATH AND DIFFERENTIATION (2008)
Immunogenic cancer cell death: a key-lock paradigm
Antoine Tesniere et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
The anticancer immune response: indispensable for therapeutic success?
Laurence Zitvogel et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
David Sancho et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma
Akash M. Mehta et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
IMMUNOLOGICAL REVIEWS (2007)
TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans
Bart Ferwerda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis
M. Obeid et al.
CELL DEATH AND DIFFERENTIATION (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Dendritic cell surface calreticulin is a receptor for NY-ESO-1: Direct interactions between tumor-associated antigen and the innate immune system
Gang Zeng et al.
JOURNAL OF IMMUNOLOGY (2006)
High mobility group box 1 protein interacts with multiple Toll-like receptors
JS Park et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Assembly of MHC class I molecules within the endoplasmic reticulum
Yinan Zhang et al.
IMMUNOLOGIC RESEARCH (2006)
Effector memory T cells, early metastasis, and survival in colorectal cancer
F Pagès et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
N Casares et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation
NE Blachèr et al.
PLOS BIOLOGY (2005)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Calreticulin expression in neuroblastoma - a novel independent prognostic factor
WM Hsu et al.
ANNALS OF ONCOLOGY (2005)
Tapasin and other chaperones: models of the MHC class I loading complex
CA Wright et al.
BIOLOGICAL CHEMISTRY (2004)
Platinums: Extending their therapeutic spectrum
FM Muggia et al.
JOURNAL OF CHEMOTHERAPY (2004)
Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections
DM Agnese et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
The danger model: A renewed sense of self
P Matzinger
SCIENCE (2002)
Corpse clearance defines the meaning of cell death
J Savill et al.
NATURE (2000)
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
NC Arbour et al.
NATURE GENETICS (2000)
Share Paper
